InvestorsHub Logo
Followers 0
Posts 1587
Boards Moderated 0
Alias Born 08/09/2015

Re: ou71764 post# 154924

Monday, 01/22/2018 6:47:45 AM

Monday, January 22, 2018 6:47:45 AM

Post# of 720716
While you are basically correct the need for IO therapies to demonstrate long tail benefits has become the driving factor in such trials, particularly with the first approval of a therapy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News